Vident U.S. Equity Strategy ETF Rating $66.58 +0.33 (+0.50%) As of 09/15/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Vident U.S. Equity Strategy ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.VUSE Aggregate RatingModerate Buy 2.83Holdings in VUSE have an aggregate rating of Moderate Buy based on 729 analyst ratings issued in the past year covering 25 companies (46.6% of the portfolio).VUSE Aggregate Price Target$66.58High Prediction$66.58Average Prediction$66.58Low Prediction$66.58Holdings in VUSE have an aggregate price target of $66.58 and a range of $66.58 to $66.58 covering 25 companies (46.6% of the portfolio).VUSE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Vident U.S. Equity Strategy ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 VUSE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.78%AVGOBroadcom$364.09+1.2%4.9453 of 5 stars3.06$356.48 -2.1%33Trending NewsAnalyst Forecast2.62%WMTWalmart$103.65+0.2%4.6611 of 5 stars3.00$110.76 6.9%31Trending News2.49%METAMeta Platforms$764.70+1.2%4.3432 of 5 stars2.96$822.41 7.5%47Positive NewsDividend Announcement2.41%VVisa$338.96-0.1%4.8794 of 5 stars2.85$385.96 13.9%26Positive News2.27%GOOGLAlphabet$251.61+4.5%3.8908 of 5 stars2.84$222.85 -11.4%45Trending NewsAnalyst Upgrade2.05%AMZNAmazon.com$231.43+1.4%4.8471 of 5 stars3.00$262.87 13.6%50Trending News2.04%COSTCostco Wholesale$960.10-0.8%4.4577 of 5 stars2.65$1,056.67 10.1%26Trending News2.03%ORCLOracle$302.10+3.4%4.685 of 5 stars2.80$303.44 0.4%35Trending NewsDividend AnnouncementAnalyst ForecastOptions VolumeAnalyst RevisionGap Up2.01%AAPLApple$236.70+1.1%4.7123 of 5 stars2.56$240.80 1.7%32Trending NewsAnalyst Forecast2.00%HDHome Depot$422.88+0.0%4.6747 of 5 stars2.81$432.52 2.3%26Positive NewsInsider Trade2.00%LLYEli Lilly and Company$748.26-0.9%4.9972 of 5 stars2.68$941.35 25.8%22Trending News1.98%ABBVAbbVie$217.92-0.2%4.7651 of 5 stars2.92$218.76 0.4%26Trending NewsAnalyst ForecastAnalyst Revision1.97%BRK.BBerkshire Hathaway$491.51-0.5%2.1876 of 5 stars3.00$575.00 17.0%1Analyst Upgrade1.97%JNJJohnson & Johnson$177.49-0.3%4.6867 of 5 stars2.65$176.29 -0.7%20Positive NewsAnalyst Upgrade1.96%JPMJPMorgan Chase & Co.$309.38+0.8%4.5238 of 5 stars2.52$291.67 -5.7%23Trending News1.95%MSFTMicrosoft$515.36+1.1%4.9271 of 5 stars2.97$612.54 18.9%32Trending NewsDividend Increase1.94%MAMastercard$583.30+0.5%4.8289 of 5 stars2.97$626.54 7.4%29Positive News1.85%NVDANVIDIA$177.750.0%4.9502 of 5 stars2.95$207.83 16.9%43Trending NewsInsider TradeAnalyst Revision1.33%NOWServiceNow$948.28+2.1%4.7664 of 5 stars2.88$1,115.20 17.6%34Positive News1.26%FTNTFortinet$81.00+1.7%4.7048 of 5 stars2.27$97.03 19.8%37Positive News1.24%GILDGilead Sciences$112.54-1.8%4.9236 of 5 stars2.89$115.39 2.5%27Positive News1.20%BKNGBooking$5,559.83+1.9%4.5155 of 5 stars2.78$5,808.81 4.5%32Positive News1.13%ADSKAutodesk$321.07+0.6%4.5834 of 5 stars2.71$356.83 11.1%24Positive News1.04%HOODRobinhood Markets$114.83-0.2%3.7682 of 5 stars2.56$101.88 -11.3%18Trending News1.03%MSIMotorola Solutions$483.41+0.4%4.9004 of 5 stars2.80$516.13 6.8%10Positive News This page (NYSEARCA:VUSE) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vident U.S. Equity Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Vident U.S. Equity Strategy ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
